Morgan Stanley Maintains Equal Weight on Phibro Animal Health Corporation (PAHC), Cites Margin Expansion

Phibro Animal Health Corporation (NASDAQ:PAHC) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds.

The seventh banal connected our database of cheap pharmaceutical stocks is Phibro Animal Health Corporation (NASDAQ:PAHC).

TheFly reported connected February 6 that Morgan Stanley accrued its terms people connected PAHC to $49 from $45 and maintained an Equal Weight rating. The steadfast cited beardown operational show successful the company’s latest quarterly results and highlighted effectual execution wrong the Animal Health conception and advancement related to the Zoetis MFA transaction. The upgrade came aft important borderline expansion, a amended fiscal 2026 forecast, and a second-quarter nett beat. Disciplined outgo power was besides cited by Morgan Stanley arsenic a important element, pointing retired that caller outcomes amusement beardown momentum successful respective important concern areas.

Adding to that, earlier connected February 4, Phibro Animal Health Corporation (NASDAQ:PAHC) revealed fiscal second-quarter results for the fiscal twelvemonth that ended connected December 31, 2025. The study shows a important betterment from twelvemonth to year, with the nett income rising 21% to $373.9 million, portion nett income accrued to $27.5 million. Adjusted EBITDA roseate 41% to $68.1 million, portion adjusted diluted EPS roseate 58% to $0.87.

A bully 4th led to an summation successful the company's fiscal 2026 estimate. PAHC has updated its full-year nett income estimates to $1.45 cardinal to $1.50 cardinal and adjusted EBITDA to $245 cardinal to $255 cardinal successful airy of improved operating momentum and accrued profitability forecasts for the remainder of the year.

Phibro Animal Health Corporation (NASDAQ:PAHC) is simply a planetary carnal wellness and nutrition institution that develops and markets vaccines, medicated provender additives, hint minerals, and specialty products to amended livestock and companion carnal health.

While we admit the imaginable of PAHC arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 12 Unstoppable Dividend Stocks to Buy According to Analysts and Dividend Champions, Contenders and Challengers list: 15 Highest Yielding Stocks.

Disclosure: None.